PMID- 15011784
OWN - NLM
STAT- MEDLINE
DCOM- 20040521
LR  - 20131121
IS  - 1464-8431 (Print)
IS  - 1464-8431 (Linking)
VI  - 6
IP  - 1
DP  - 2004 Feb
TI  - Fashioning regulatory dendritic cells: what is currently in vogue?
PG  - 78-82
AB  - Dendritic cells (DCs) are uniquely well-equipped antigen-presenting cells with 
      remarkable plasticity, whose differentiation and function can be manipulated in 
      vitro and in vivo. With increased understanding of their immunoregulatory 
      properties, strategies to enhance DC tolerogenicity have emerged. Carefully 
      fashioned DCs, the result of biological, pharmacological or genetic modification, 
      hold promise as new cell-based therapies of organ allograft rejection and 
      autoimmune diseases.
FAU - Taner, Timucin
AU  - Taner T
AD  - University of Pittsburgh Medical Center, Thomas E Starzl Transplantation 
      Institute, Department of Surgery, 200 Lothrop Street, Biomedical Science Tower 
      W1544, Pittsburgh, PA 15213, USA.
FAU - Thomson, Angus W
AU  - Thomson AW
LA  - eng
GR  - AI/DK51698/AI/NIAID NIH HHS/United States
GR  - AI41011/AI/NIAID NIH HHS/United States
GR  - DK49745/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PT  - Review
PL  - England
TA  - Curr Opin Mol Ther
JT  - Current opinion in molecular therapeutics
JID - 100891485
SB  - IM
MH  - Animals
MH  - Antigen Presentation
MH  - Autoimmune Diseases/therapy
MH  - Autoimmunity
MH  - Cell Differentiation
MH  - Cell- and Tissue-Based Therapy
MH  - Cells, Cultured
MH  - Dendritic Cells/*immunology
MH  - Genetic Engineering
MH  - Humans
MH  - Immune Tolerance
MH  - Models, Biological
MH  - Transplantation Tolerance
RF  - 41
EDAT- 2004/03/12 05:00
MHDA- 2004/05/22 05:00
CRDT- 2004/03/12 05:00
PHST- 2004/03/12 05:00 [pubmed]
PHST- 2004/05/22 05:00 [medline]
PHST- 2004/03/12 05:00 [entrez]
PST - ppublish
SO  - Curr Opin Mol Ther. 2004 Feb;6(1):78-82.